课题基金 / 基金详情

GENETICS/DIAGNOSIS OF HEREDITARY FRUCTOSE INTOLERANCE

GENETICS/DIAGNOSIS OF HEREDITARY FRUCTOSE INTOLERANCE
遗传性果糖不耐受症的遗传学/诊断
批准号:
2905436
负责人:
Dean R. TOLAN
金额:
$16.51万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-05-01 至 2004-08-31

项目摘要

项目成果

Dean R. TOLAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from the applicant's abstract) This proposal is directed toward understanding the molecular basis of a human metabolic disorder of carbohydrate metabolism, hereditary fructose intolerance (HFI), as well as its causes, distribution, and biochemical and physiological effects. These studies will directly test hypotheses that may explain the normal gluconeogenesis that HFI patients exhibit in the absence of fructose, and therefore, may lead to a better understanding of glucose homeostasis in humans. The specific aims of the proposed investigations are: 1) the identification of mutations in the DNA from individuals with HFI in the American population, and 2) the determination of the biochemical roots of this disorder by examination of both the normal enzyme, aldolase B, and the enzymes produced from HFI alleles containing missense mutations. First, the polymerase chain reaction (PCR) will be employed to amplify DNA from blood samples of American HFI patients for the identification of known mutations by allele specific oligonucleotide hybridization (ASO), direct PCR analysis, or amplification refractory mutation (ARM) analysis. Second, for those HFI subjects who do not carry any of the 21 known mutations, similar PCR amplification of several gene fragments encoding the entire aldolase B sequence will be used for identification of new mutations. These mutations will be identified by direct sequence determination using a third primer in PCR assisted cycle sequencing. Segregation analysis of any new mutations will give genetic evidence that these mutations cause HFI. Third, site-directed mutagenesis will be performed to generate mutant enzymes containing HFI missense mutations. These HFI enzymes will be expressed and purified as fusion proteins to glutathione-S-transferase (GST). Fourth, structural and functional analyses will determine if the HFI enzymes have any residual activity. Fifth, the enzymology of normal aldolase B will be examined by measurement of the levels of several covalent reaction intermediates (Schiff base, enamine, etc.) by chemical trapping and the rates of their formation and interconversion (Schiff base, carbon-carbon bond cleavage, proton abstraction) by rapid quenching during single turnover experiments. Lastly, stable HFI enzymes will be examined in similar experiments to assess the nature of the biochemical defects that causes HFI.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Metabolic Pathways and Defects in Fructose Metabolism
Metabolic Pathways and Defects in Fructose Metabolism
Metabolic Pathways and Defects in Fructose Metabolism
Metabolic Pathways and Defects in Fructose Metabolism
海外基金